ENDOTAG Trademark

Trademark Overview

On Friday, May 27, 2005, a trademark application was filed for ENDOTAG with the United States Patent and Trademark Office. The USPTO has given the ENDOTAG trademark a serial number of 79020593. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, May 28, 2015. This trademark is owned by MediGene AG. The ENDOTAG trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Services of a molecular biological or pharmaceutical laboratory, namely, research and development in the field of human medical and veterinary medical diagnostics and therapy by means of molecular biological, genetic engineering, biotechnological, chemical and pharmaceutical methods; development of pharmaceutical preparations and medicines; screening, namely testing of chemical or biological compounds for pharmaceutically effective properties; development of diagnostic testing processes and test kits
endotag

General Information

Serial Number79020593
Word MarkENDOTAG
Filing DateFriday, May 27, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, May 28, 2015
Registration Number3249792
Registration DateTuesday, June 5, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2006

Trademark Statements

Goods and ServicesServices of a molecular biological or pharmaceutical laboratory, namely, research and development in the field of human medical and veterinary medical diagnostics and therapy by means of molecular biological, genetic engineering, biotechnological, chemical and pharmaceutical methods; development of pharmaceutical preparations and medicines; screening, namely testing of chemical or biological compounds for pharmaceutically effective properties; development of diagnostic testing processes and test kits
Transformation Information76677125

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 10, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMediGene AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMediGene AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMediGene AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, December 11, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 11, 2015DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 6, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, April 3, 2015GENERIC MADRID TRANSACTION SENT TO IB
Friday, April 3, 2015GENERIC MADRID TRANSACTION CREATED
Wednesday, September 10, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 10, 2014CANCELLED SECTION 71
Thursday, August 28, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 2, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 2, 2007FINAL DISPOSITION PROCESSED
Thursday, October 25, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 5, 2007REGISTERED-PRINCIPAL REGISTER
Friday, April 6, 2007EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, March 9, 2007LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Friday, March 2, 2007LIMITATION OF GOODS RECEIVED FROM IB
Saturday, November 25, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 21, 2006PUBLISHED FOR OPPOSITION
Wednesday, November 1, 2006NOTICE OF PUBLICATION
Friday, September 29, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 29, 2006ASSIGNED TO LIE
Saturday, September 23, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 15, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 14, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 14, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 7, 2006REFUSAL PROCESSED BY IB
Thursday, March 16, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 15, 2006REFUSAL PROCESSED BY MPU
Tuesday, March 14, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 13, 2006NON-FINAL ACTION WRITTEN
Friday, March 10, 2006ASSIGNED TO EXAMINER
Friday, March 10, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, March 9, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

endotag pharmaceutical development biological testing medical namely chemical molecular compounds screening